Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain
Journal of Opioid Management · 2012
DOI: 10.5055//jom.2012.0101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Opioid Management, 2012. Verfasst von Felix A. De la Iglesia und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Objectives
Analgesic synergy and improved tolerability have been reported for flexible dose morphine and oxycodone combinations. This report describes two studies with similar double-blind, randomized, 7-day crossover designs (up to 7 days per arm) conducted to 1) explore the analgesic and safety benefit of fixed ratio of morphine (M) and oxycodone (O) combinations (MOX) and 2) define the optimal ratio for morphine and oxycodone combination.
Setting
Clinical study centers in Australia.Patients: Patients with chronic noncancer pain.
Intervention
Eligible patients were randomly assigned to receive flexible doses of either M or fixed ratio of MOX (M3:O2 in study A; M1:O2 in study B). The starting doses of M or MOX were the morphine equivalent doses (MEDs) converted from the analgesics received before entering double-blind treatment. At each crossover period, the doses were titrated to achieve analgesia at steady state, which was defined as when the same total daily dose (±10 percent) had been given consecutively for 3 days.Main outcome measure: The primary endpoint was the study medication dose (MED), which produced adequate pain control at steady state.
Results
Analgesic synergy in MOX was observed in both studies. On an MED basis, 61.6 percent (study A, M:O = 3:2) or 46.8 percent (study B, M:O = 1:2) more MED were needed for M monotherapy to achieve steady-state pain control when compared with MOX. Patient tolerability profiles were also generally better in the MOX groups.
Conclusion
A 3:2 or1:2 fixed ratio combination of morphine and oxycodone (MOX) produced analgesic synergy and a tolerability profile improvement in patients with chronic noncancer pain.
Zitieren
APA
Iglesia, F. A. D. L., MD, Pace, G. W., PhD, Robinson, G. L. W. G., PhD, Huang, N., MD, PhD, Stern, W., PhD, Richards, P., MD, & PhD (2012). Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain. Journal of Opioid Management. https://doi.org/10.5055//jom.2012.0101
Vancouver
Iglesia FADL, MD, Pace GW, PhD, Robinson GLWG, PhD, et al. Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain. Journal of Opioid Management. 2012. doi:10.5055//jom.2012.0101
BibTeX
@article{Iglesia2012,
author = {Iglesia, Felix A. De la and MD and Pace, Gary W. and PhD and Robinson, Gary L. W. G. and PhD and Huang, Nuo-Yu and MD and PhD and Stern, Warren and PhD and Richards, Patricia and MD and PhD},
title = {Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain},
journal = {Journal of Opioid Management},
year = {2012},
doi = {10.5055//jom.2012.0101}
}
EUVIMED